Patents by Inventor Karen Reddin

Karen Reddin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified whole cell, cell extract and omv-based vaccines
    Publication number: 20070154495
    Abstract: Live vaccines, live-attenuated vaccines, dead vaccines, protein preparations for use in vaccines and OMVs for use in vaccines are free of CEACAM1-binding Opa, though max contain Opa variants that are antigenic but don't bind to CEACAM1.
    Type: Application
    Filed: October 8, 2004
    Publication date: July 5, 2007
    Applicant: Health Protection Agency
    Inventors: Andrew Gorringe, Karen Reddin, Scott Gray-Owen, Ian Boulton
  • Outer membrane vesicles from gram negative bacteria and use as a vaccine
    Publication number: 20050013831
    Abstract: A composition is prepared from a mixture of different vesicles, such as outer membrane vesicles (OMVs) and vaccines are based thereon. Another composition comprises in a single vesicle a combination of antigens and/or other vesicle components deriving from separate vesicles; again vaccines are prepared therefrom.
    Type: Application
    Filed: December 17, 2002
    Publication date: January 20, 2005
    Inventors: Keith Foster, Andrew Gorringe, Michael Hudson, Karen Reddin, Andrew Robinson